Literature DB >> 35110232

Providing Free Access to Smoking Cessation Medications: Does It Have an Impact on the Treatment Adherence and Success of Smoking Cessation?

Olesya Aksel1, Nevin Küçüktepe2, Zafer Yaslıca2, Okay Başak2.   

Abstract

OBJECTIVE: Providing medications to patients free of charge is thought to be one of the factors affecting the success of smoking cessation. The aim of this study was to investigate the effect of providing free access to stop-smoking medications on the treatment adherence and short term success of quitting smoking.
MATERIAL AND METHODS: All smokers who applied to a smoking cessation outpatient clinic between September 2017 and December 2019 were included in this retrospective study. Data were collected from patients' files filled using an initial evaluation and follow-up protocol.
RESULTS: During the study period, 518 smokers applied to our polyclinic for smoking cessation counseling. Medical therapy was prescribed for 411 (85.4%) of 481 patients who were supported by behavioral therapy. The patients had a mean age of 41.2 years, and 64.7% were male. Only 22.9% of smokers prescribed stop-smoking medications were able to obtain them for free. Patients who got the medications completely free of charge were 4 times more adherent to treatment. The success rate of quitting smoking at the end of the third month was 22.2%. The strongest effect was achieved by the full treatment compliance. At the end of 3 months, the success of quitting smoking was 14.1 times higher for those who were fully adherent to treatment than non-adherents. DISCUSSION: According to our study results, the most effective success factors in short-term smoking cessation are patient compliance to treatment and free supply of stop-smoking medications, one of the main determinants of treatment adherence.

Entities:  

Year:  2021        PMID: 35110232      PMCID: PMC8975362          DOI: 10.5152/TurkThoracJ.2021.20124

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  12 in total

1.  Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.

Authors:  James Balmford; Ron Borland; David Hammond; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2010-12-08       Impact factor: 4.244

2.  Can a Computer-Based Prescription of Free Medication Increase Smoking Cessation Rates Efficiently?

Authors:  Banu Salepci; Ali Fidan; Benan Çağlayan; Elif Torun Parmaksız; Nesrin Kıral; Sevda Şener Cömert; Gülten Aktin Güngör; Egehan Salepci
Journal:  Turk Thorac J       Date:  2015-12-14

3.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

4.  Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis.

Authors:  M Atilla Uysal; Figen Kadakal; Cağatay Karşidağ; Nazan Gülhan Bayram; Omer Uysal; Veysel Yilmaz
Journal:  Tuberk Toraks       Date:  2004

5.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

Review 6.  Healthcare financing systems for increasing the use of tobacco dependence treatment.

Authors:  Floor A van den Brand; Gera E Nagelhout; Ayalu A Reda; Bjorn Winkens; Silvia M A A Evers; Daniel Kotz; Onno Cp van Schayck
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

7.  Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

Authors:  Benjamin Cadier; Isabelle Durand-Zaleski; Daniel Thomas; Karine Chevreul
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

8.  A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme.

Authors:  Ali Ramazan Benli; Selman Erturhan; Muhammet Ali Oruc; Pinar Kalpakci; Didem Sunay; Yeltekin Demirel
Journal:  Tob Induc Dis       Date:  2017-02-01       Impact factor: 2.600

9.  Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.

Authors:  Marta Trapero-Bertran; Celia Muñoz; Kathryn Coyle; Doug Coyle; Adam Lester-George; Reiner Leidl; Bertalan Németh; Kei-Long Cheung; Subhash Pokhrel; Ángel Lopez-Nicolás
Journal:  Addiction       Date:  2018-03-13       Impact factor: 6.526

10.  Is Cost of Medication for Quit Smoking Important for Smokers, Experience of Using Champix in Iranian Smoking Cessation Program 2016.

Authors:  Gholamreza Heydari
Journal:  Int J Prev Med       Date:  2017-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.